Stock News

Merck (MRK) Q4 2022 Earnings Call Transcript
Merck Beats On Q4 earnings, Anticipates Almost 80% Decline In COVID-19 Treatment Sales In 2023
UPDATE 2-Merck sees sharp decline in COVID sales for 2023 after strong fourth quarter
Merck Stock Slumps As 2023 Profit Outlook Clouds Q4 Earnings Beat
Merck sees sharp decline in COVID sales for 2023 after strong fourth quarter
Merck fourth quarter tops expectations on strong COVID pill sales
15 Undervalued Defensive Stocks For 2023
Is Merck & Co. (MRK) a Long-Term Bet?
Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for BRAVECTO (fluralaner) Chews for Dogs

As seen on...